Press releases | WebDisclosure

Basculer en Français

11293	Companies
250965	Keywords
179876	Articles
136835	Press releases

Home
Press releases

PRESS RELEASE

published on 09/25/2025 at 23:30, 1 year 1 month ago

EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States
EssilorLuxottica's Essilor Stellest lens, the first FDA market authorized spectacle lens in the U.S., clinically proven to slow myopia progression in children, with 71% effectiveness over 2 years

Clinical Data EssilorLuxottica FDA Market Authorization Spectacle Lens Myopia Progression
PRESS RELEASE

published on 09/25/2025 at 23:30, 1 year 1 month ago

EssilorLuxottica: Essilor Stellest est le tout premier verre optique à recevoir de la FDA une autorisation de mise sur le marché aux États-Unis
EssilorLuxottica obtient l'autorisation de la FDA pour le verre Essilor Stellest, unique pour ralentir la myopie chez les enfants. Étude clinique démontre un ralentissement de 71% sur 2 ans

FDA Autorisation EssilorLuxottica Verre Essilor Stellest Myopie Infantile
PRESS RELEASE

published on 09/25/2025 at 23:15, 1 year 1 month ago

Northern Dynasty: Fourth Tranche of $12 million Royalty Investment Received, Update on Government Discussions and Court Filings
Northern Dynasty Minerals Ltd. announces receipt of $12 million payment as the fourth tranche of investment under the royalty agreement, maintaining a strong treasury position for project development

Northern Dynasty Minerals Ltd. Project Development Royalty Agreement $12 Million Payment Treasury Position
PRESS RELEASE

published on 09/25/2025 at 22:15, 1 year 1 month ago

Rapports financiers et d'audit semestriels/examens réduits / Modalités de mise à disposition du rapport financier semestriel
Aelis Farma annonce la mise \u00e0 disposition du rapport financier semestriel 2025 et pr\u00e9sente ses avanc\u00e9es en innovation th\u00e9rapeutique avec les inhibiteurs sp\u00e9cifiques du r\u00e9cepteur CB1

Rapport Financier Aelis Farma Innovation Th\u00e9rapeutique CB1 Sant\u00e9
PRESS RELEASE

published on 09/25/2025 at 22:15, 1 year 1 month ago

Half yearly financial reports and audit reports/limited reviews / Terms of availability of the half-yearly financial report
Aelis Farma announces availability of 2025 half-year financial report. Company specializes in CB1 receptor treatments for brain and peripheral diseases

Financial Report Aelis Farma CB1 Receptor Brain Diseases Peripheral Diseases
PRESS RELEASE

published on 09/25/2025 at 22:15, 1 year 1 month ago

SMX and CETI Launch an Industrial Validation Program to Drive Circular-Economy and Traceability in Textiles & Fabrics
SMX (Security Matters) PLC and CETI collaborate to bring molecular traceability to European textile and fashion industry, aiming for circular economy and sustainable practices

Circular Economy Traceability SMX CETI European Textile
PRESS RELEASE

published on 09/25/2025 at 20:30, 1 year 1 month ago

ADM Toronto Keynotes Highlight Canada's Manufacturing Landscape
ADM Toronto 2025 features top speakers discussing critical challenges and opportunities in Canada's manufacturing sector. Event covers sectors like packaging, automation, and EV technology

Manufacturing Challenges Opportunities ADM Toronto 2025 Speakers
PRESS RELEASE

published on 09/25/2025 at 20:16, 1 year 1 month ago

Informations privilégiées / Communiqué sur comptes, résultats
ABIONYX Pharma annonce ses résultats financiers du 1er semestre 2025. Chiffre d'affaires de 2,1 M€, pertes réduites. Trésorerie à 3,4 M€. Lauréat du plan France 2030

Chiffre D'affaires Résultats Financiers Trésorerie ABIONYX Pharma 1er Semestre 2025
PRESS RELEASE

published on 09/25/2025 at 20:16, 1 year 1 month ago

Inside Information / News release on accounts, results
ABIONYX Pharma announces its 2025 half-year financial results, including revenue of €2.1 million and ongoing initiatives in biotech innovation. Company receives government support for sepsis research

Revenue Biotech Innovation ABIONYX Pharma 2025 Financial Results Sepsis Research
PRESS RELEASE

published on 09/25/2025 at 20:04, 1 year 1 month ago

Inside Information / Other news releases
Arverne releases its 2025 half-year financial report, including activity report, financial statements, and auditor's report. Available on Arverne and AMF websites

AMF Financial Report French Geothermal Solutions Arverne

Accesswire

Published on 11/06/2026 at 22:15, 14 hours 18 minutes ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 23 hours 33 minutes ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 1 day ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 1 day ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 1 day 2 hours ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/06/2026 at 20:15, 16 hours 17 minutes ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 16 hours 17 minutes ago

L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 17 hours 17 minutes ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 17 hours 32 minutes ago

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 18 hours ago

EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond

Les Echos

Published on 11/06/2026 at 19:06, 17 hours 26 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 17 hours 28 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 17 hours 31 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 17 hours 33 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 18:00, 18 hours 33 minutes ago

ICADE - CP - Notation crédit S&P

View all LES ECHOS COMFI WIRE